Keywords
chronic gastritis, H.pylori infection, atrophy, metaplasia, dysplasia
How to Cite
Kuryk, O. G., & Kolomoyets, M. Y. (2018). Chronic gastritis. Clinical and Preventive Medicine, (1), 85-98. https://doi.org/10.31612/2616-4868.1-4.2018.11
Abstract
The modern clinico-morphological classification of chronic gastritis was given. H.pylori as a main ethiological factor of chronic gastritis was determined. The determination of atrophy of gastric mucosa was given, and we accented, that atrophy may be imitating by inflamate infiltrate. Two types of atrophy – metaplastic and non-metaplastic was examined. The types of metaplasia of gastric mucosa – full (intestinal) and non-full (colon) and the role of colon metaplasia in genesis of gastric cancer was given. The characteristic of dysplasia, its criteria and difficulty of diagnostic was given. Two ways of cancerogenesis of gastric cancer with H.pylori as cancerogene of I group was examined. Some another forms of non-helicobacter chronic gastritis was showen.
References
1. Ben Slama S., Ben Ghachem D., Dhaoui A., Jomni M.T., Dougui M.H., Bellil K. (2016). Helicobacter pylori gastritis: assessment of OLGA and OLGIM staging systems. Pan Afr. Med. J., 4, 23-28. doi: 10.11604/pamj.2016.23.28.8839.
2. Capelle L..G, de Vries A.C., Haringsma J., Ter Borg F., de Vries R.A., Bruno M.J., van Dekken H., Meijer J., van Grieken N.C., Kuipers E.J. (2010). The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest. Endosc., 71, 1150–1158. doi: 10.1016/j.gie.2009.12.029.
3. Correa P. (1995) Helicobacter pyloriand carcinogenesis. Am. J. Surg. Pathol., 19, 37-43.
4. Dinis-Ribeiro M., Areia M., de Vries A.C., Marcos-Pinto R., Monteiro-Soares M., O’Connor A., Pereira C., Pimentel-Nunes P., Correia R, Ensari A. (2012). Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) Endoscopy, 44, 74–94. doi: 10.1055/s-0031-1291491.
5. Isajevs S., Liepniece-Karele I., Janciauskas D., Moisejevs G., Putnins V., Funka K., Kikuste I., Vanags A., Tolmanis I., Leja M. (2014). Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch., 464, 403–407. doi: 10.1007/s00428-014-1544-3.
6. Marcos-Pinto R., Carneiro F., Dinis-Ribeiro M., Wen X., Lopes C., Figueiredo C., Machado J.C., Ferreira R.M., Reis C.A., Ferreira J. (2012). First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment. Pharmacol. Ther., 35, 1451–1459. doi.org/10.1111/j.1365-2036.2012.05111.
7. Nam J.H., Choi I.J., Kook M.C., Lee J.Y., Cho S.J., Nam S.Y., Kim C.G. (2014). OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Helicobacter, 19, 81–89. doi.org/10.1111/hel.12112.
8. Quach D.T., Le H.M., Nguyen O.T, Nguyen T.S., Uemura N. (2011). The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J. Gastroenterol. Hepatol., 26, 281–285. doi: 10.1111/j.1440-1746.2010.06474.x.
9. Quach D.T., Le H.M., Hiyama T., Nguyen O.T., Nguyen T.S., Uemura N. (2013). Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter, 18, 151–157. doi: 10.1111/hel.12027.
10. Rugge M., Correa P., Di Mario F., El-Omar E., Fiocca R., Geboes K., Genta R.M., Graham D.Y., Hattori T., Malfertheiner P. (2008). OLGA staging for gastritis: a tutorial. Dig. Liver Dis., 40, 650–658. doi: 10.1177/1066896907307238.
11. Rugge M., de Boni M., Pennelli G., de Bona M., Giacomelli L., Fassan M., Basso D., Plebani M., Graham D.Y. (2010). Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment. Pharmacol Ther., 31, 1104–1111. doi: 10.1111/j.1365-2036.2010.04277.
12. Rugge M., Fassan M., Pizzi M., Farinati F., Sturniolo G.C., Plebani M., Graham D.Y. (2011). Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J. Gastroenterol., 17, 4596–4601. doi: 10.1016/j.humpath.2010.12.017.
13. Rugge M., Pennelli G., Pilozzi E., Fassan M., Ingravallo G., Russo V.M., Di Mario F. (2011). Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Gastritis: the histology report. Dig. Liver Dis., 43(4), 373-84. doi: 10.1016/S1590-8658(11)60593-8.
14. Saf C., Gulcan E.M., Ozkan F. Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis. Eur. J. Gastroenterol. Hepatol. 2015. 27(2). P.155-161. doi: 10.1097/MEG.0000000000000246.
15. Yue H, Shan L, Bin L. (2018) The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer.,21(4), 579-587. doi: 10.1007/s10120-018-0812-3.
16. Zhou Y., Li H.Y., Zhang J.J., Chen X.Y., Ge Z.Z., Li X.B. (2016). Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J. Gastroenterol., 22(13), 3670-8. doi: 10.3748/wjg.v22.i13.3670.
2. Capelle L..G, de Vries A.C., Haringsma J., Ter Borg F., de Vries R.A., Bruno M.J., van Dekken H., Meijer J., van Grieken N.C., Kuipers E.J. (2010). The staging of gastritis with the OLGA system by using intestinal metaplasia as an accurate alternative for atrophic gastritis. Gastrointest. Endosc., 71, 1150–1158. doi: 10.1016/j.gie.2009.12.029.
3. Correa P. (1995) Helicobacter pyloriand carcinogenesis. Am. J. Surg. Pathol., 19, 37-43.
4. Dinis-Ribeiro M., Areia M., de Vries A.C., Marcos-Pinto R., Monteiro-Soares M., O’Connor A., Pereira C., Pimentel-Nunes P., Correia R, Ensari A. (2012). Management of precancerous conditions and lesions in the stomach (MAPS): guideline from the European Society of Gastrointestinal Endoscopy (ESGE), European Helicobacter Study Group (EHSG), European Society of Pathology (ESP), and the Sociedade Portuguesa de Endoscopia Digestiva (SPED) Endoscopy, 44, 74–94. doi: 10.1055/s-0031-1291491.
5. Isajevs S., Liepniece-Karele I., Janciauskas D., Moisejevs G., Putnins V., Funka K., Kikuste I., Vanags A., Tolmanis I., Leja M. (2014). Gastritis staging: interobserver agreement by applying OLGA and OLGIM systems. Virchows Arch., 464, 403–407. doi: 10.1007/s00428-014-1544-3.
6. Marcos-Pinto R., Carneiro F., Dinis-Ribeiro M., Wen X., Lopes C., Figueiredo C., Machado J.C., Ferreira R.M., Reis C.A., Ferreira J. (2012). First-degree relatives of patients with early-onset gastric carcinoma show even at young ages a high prevalence of advanced OLGA/OLGIM stages and dysplasia. Aliment. Pharmacol. Ther., 35, 1451–1459. doi.org/10.1111/j.1365-2036.2012.05111.
7. Nam J.H., Choi I.J., Kook M.C., Lee J.Y., Cho S.J., Nam S.Y., Kim C.G. (2014). OLGA and OLGIM stage distribution according to age and Helicobacter pylori status in the Korean population. Helicobacter, 19, 81–89. doi.org/10.1111/hel.12112.
8. Quach D.T., Le H.M., Nguyen O.T, Nguyen T.S., Uemura N. (2011). The severity of endoscopic gastric atrophy could help to predict Operative Link on Gastritis Assessment gastritis stage. J. Gastroenterol. Hepatol., 26, 281–285. doi: 10.1111/j.1440-1746.2010.06474.x.
9. Quach D.T., Le H.M., Hiyama T., Nguyen O.T., Nguyen T.S., Uemura N. (2013). Relationship between endoscopic and histologic gastric atrophy and intestinal metaplasia. Helicobacter, 18, 151–157. doi: 10.1111/hel.12027.
10. Rugge M., Correa P., Di Mario F., El-Omar E., Fiocca R., Geboes K., Genta R.M., Graham D.Y., Hattori T., Malfertheiner P. (2008). OLGA staging for gastritis: a tutorial. Dig. Liver Dis., 40, 650–658. doi: 10.1177/1066896907307238.
11. Rugge M., de Boni M., Pennelli G., de Bona M., Giacomelli L., Fassan M., Basso D., Plebani M., Graham D.Y. (2010). Gastritis OLGA-staging and gastric cancer risk: a twelve-year clinico-pathological follow-up study. Aliment. Pharmacol Ther., 31, 1104–1111. doi: 10.1111/j.1365-2036.2010.04277.
12. Rugge M., Fassan M., Pizzi M., Farinati F., Sturniolo G.C., Plebani M., Graham D.Y. (2011). Operative link for gastritis assessment vs operative link on intestinal metaplasia assessment. World J. Gastroenterol., 17, 4596–4601. doi: 10.1016/j.humpath.2010.12.017.
13. Rugge M., Pennelli G., Pilozzi E., Fassan M., Ingravallo G., Russo V.M., Di Mario F. (2011). Gruppo Italiano Patologi Apparato Digerente (GIPAD); Società Italiana di Anatomia Patologica e Citopatologia Diagnostica/International Academy of Pathology, Italian division (SIAPEC/IAP). Gastritis: the histology report. Dig. Liver Dis., 43(4), 373-84. doi: 10.1016/S1590-8658(11)60593-8.
14. Saf C., Gulcan E.M., Ozkan F. Assessment of p21, p53 expression, and Ki-67 proliferative activities in the gastric mucosa of children with Helicobacter pylori gastritis. Eur. J. Gastroenterol. Hepatol. 2015. 27(2). P.155-161. doi: 10.1097/MEG.0000000000000246.
15. Yue H, Shan L, Bin L. (2018) The significance of OLGA and OLGIM staging systems in the risk assessment of gastric cancer: a systematic review and meta-analysis. Gastric Cancer.,21(4), 579-587. doi: 10.1007/s10120-018-0812-3.
16. Zhou Y., Li H.Y., Zhang J.J., Chen X.Y., Ge Z.Z., Li X.B. (2016). Operative link on gastritis assessment stage is an appropriate predictor of early gastric cancer. World J. Gastroenterol., 22(13), 3670-8. doi: 10.3748/wjg.v22.i13.3670.
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.